January 31st, 2026
Description
This activity will address new diagnostic criteria and tools, emerging endoscopic and surgical treatments, as well as new medical and lifestyle strategies for treating esophageal disorders. Presentations will include current diagnostic standards and technologies, like pH testing and EndoFLIP; endoscopic and surgical treatments like TIF, LINX, and Reflux Stop; as well as the opportunity for hands-on practice with these tools; and new medical therapies, including PPIs, Vonoprozan, and GLP-1s.
For pricing information, see pricing tab below.
Dates and Times
Start: 1/31/2026 8:00 AM
End: 1/31/2026 4:00 PM
Objectives
At the conclusion of this activity, learners will be able to:
1. Apply updated diagnostic criteria to improve evaluation of esophageal disorders.
2. Differentiate between endoscopic and surgical interventions based on clinical indications.
3. Integrate current evidence on medical therapies into individualized treatment plans.
4. Evaluate the potential of AI technology to enhance GERD diagnosis and care.
Agenda
Pricing
| Tier | Price |
|---|---|
| Physician attending in person | $0.00 |
| Physician participating online | $0.00 |
| Non-physician attending in person | $0.00 |
| Non-physician participating online | $0.00 |
Location
The Ohio State University Wexner Medical Center
Biological Research Tower
460 W. 12th Avenue, Room 115
Columbus, OH 43210
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 5.50 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.